Literature DB >> 26360138

A retrospective review of the incidence of various complications in different delayed breast reconstruction methods.

Andri Thorarinsson1, Victoria Fröjd1, Lars Kölby1, Richard Lewin1, Niclas Molinder1, Jonas Lundberg1, Anna Elander1, Hans Mark1.   

Abstract

BACKGROUND: Breast reconstruction is a common standard procedure in many centres after breast cancer surgery. The aim of the present study was to investigate and compare the incidence of various complications in different reconstruction methods.
METHOD: Six hundred and eighty-five patients were retrospectively classified into five groups: (1) Deep inferior epigastric perforator flap (DIEP), (2) latissimus dorsi flap (LD), (3) lateral thoracodorsal flap (LTDF), (4) expander with secondary implant (EXP), and (5) direct implant (DI). Demographic and perioperative data, the incidence of complications, and follow-up data were collected.
RESULTS: There was a significant difference between groups regarding overall early complications (p < 0.001). The DIEP group had the highest incidence of overall complications (50.0%) (p < 0.05). DIEP also had the highest incidence of fat necrosis (18.3%), skin necrosis (22.1%), and incidence of reoperation for complications (26.9%) compared to the other reconstruction methods. In the entire group of patients, the overall incidence of late complications (occurring >30 days after surgery) that needed surgical corrections was 54.7%. The incidence of late complications was 46.2% for DIEP, 66.4% for LD, 74.8% for LTDF, 44.9% for EXP, and 62.9% for DI. The DIEP group had higher incidences of late local complications (fat necrosis, skin necrosis, haematoma, seroma, and wound rupture combined), and scars requiring treatment than the other reconstruction methods.
CONCLUSION: Meticulous registration of incidence of different complications in five different breast reconstruction methods revealed high complication rates with all methods. The differences in incidence of complications were related to the operation method used. Based on these results, careful individual planning of a breast reconstruction is mandatory.

Entities:  

Keywords:  breast cancer; breast reconstruction; surgical complications

Mesh:

Year:  2015        PMID: 26360138     DOI: 10.3109/2000656X.2015.1066683

Source DB:  PubMed          Journal:  J Plast Surg Hand Surg        ISSN: 2000-6764


  7 in total

1.  The effect of sarcopenic obesity and muscle quality on complications after DIEP-flap breast reconstruction.

Authors:  N Sadok; M E Hartmans; G H de Bock; J M Klaase; P M N Werker; A R Viddeleer; L Jansen
Journal:  Heliyon       Date:  2022-05-11

2.  Patient determinants as independent risk factors for postoperative complications of breast reconstruction.

Authors:  Andri Thorarinsson; Victoria Fröjd; Lars Kölby; Mattias Lidén; Anna Elander; Hans Mark
Journal:  Gland Surg       Date:  2017-08

3.  Oncoplastic technique using a lateral mammary adipofascial flap for the breast-conserving reconstruction.

Authors:  Jiang Wu; Changjiao Yan; Lei Wang; Yuqing Yang; Rui Ling; Nanlin Li
Journal:  Ann Transl Med       Date:  2019-12

4.  Long-Term Health-Related Quality of Life after Breast Reconstruction: Comparing 4 Different Methods of Reconstruction.

Authors:  Andri Thorarinsson; Victoria Fröjd; Lars Kölby; Johan Ljungdal; Charles Taft; Hans Mark
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-06-21

5.  The Use of Local Perforator Flaps in Delayed or Secondary Breast Reconstruction.

Authors:  Edel Marie Quinn; Siobhan O'Ceallaigh; Lyndsey Highton; John Murphy
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-12-17

6.  Standardization and Selection of High-risk Patients for Surgical Wound Infections in Plastic Surgery.

Authors:  Marta Starnoni; Massimo Pinelli; Silvia Porzani; Alessio Baccarani; Giorgio De Santis
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-03-23

7.  Predictive risk factors of complications in different breast reconstruction methods.

Authors:  J S Palve; T H Luukkaala; M T Kääriäinen
Journal:  Breast Cancer Res Treat       Date:  2020-05-28       Impact factor: 4.872

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.